LINEZOLID

The positive predictive value depends on a disease prevalence in society [28]. the inclusion criteria. We stratified them according to age ( 5 and 5 years old) and COVID-19 status. The majority of children experienced clinical and laboratory features of Kawasaki Fmoc-Val-Cit-PAB-PNP disease, probably non-associated with COVID-19. However, children 5 years of age had PIMS characteristics, and nine children had COVID-19 confirmation. This is, to our knowledge, the first statement of the PIMS register from a country with a low COVID-19 prevalence, and it proves that PIMS may emerge in any area involved in the COVID-19 pandemic. In a context of limited COVID-19 screening availability, other risk factors of PIMS, e.g., older age, should be considered in the differential diagnosis of inflammatory syndromes in children. = 39)= 25)= 14)= 9)= 18)= 12) 0.05). Table 3 Clinical course and outcomes, according to age group and SARS-CoV-2 status. = 39)= 25)= 14)= 9)= 18)= 12) 0.05). Table 4..